Ascendis Pharma A/SASNDNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P93
Near historical high
vs 2Y Ago
2.8x
Strong expansion
Streak
6 yr
Consecutive growthAccelerating
PeriodValue
202553.05%
202438.81%
202318.92%
2022-24.35%
2021-36.65%
2020-45.83%
2019-46.50%
2018-38.74%
2017-52.96%
2016-74.35%